The FDA announced on Sept. 29, 2026, that Teva Pharmaceuticals USA, Inc. is recalling Metoclopramide Tablets, USP, 5 mg due to the presence of foreign tablets or capsules. The recall affects 240,448 cartons distributed nationwide. Owners should stop using the product immediately.
How to tell if you have it
- Brand: Teva Pharmaceuticals
- Product: Metoclopramide Tablets, USP, 5 mg
- Packaging: 100 or 500 tablets per bottle
- NDC 100 Tablets: 0093-2204-01
- NDC 500 Tablets: 0093-2204-05
- Lot numbers (100 Tablets): 8634085, 8635085, 8636085
- Lot number (500 Tablets): 8633085
- Expiration date: 07/2027
- Distribution: US Nationwide
The hazard
The recall is due to the presence of foreign tablets or capsules in the Metoclopramide bottles. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Teva Pharmaceuticals USA, Inc. has 60 other recalls on record since April 2, 2012. Other recent recalls of similar products include Teva recalling traZODone 50mg tablets with foreign tablets risk (Aug. 24, 2026) and American Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence (Oct. 6, 2026).